Vimarsana
Biggest News Aggregation in the World

Stuartj Pocock News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stuartj Pocock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stuartj Pocock Today - Breaking & Trending Today

TCT 2024 Career Achievement Award to be Presented to Robert A. Harrington, MD - Vimarsana News

TCT 2024 Career Achievement Award to be Presented to Robert A. Harrington, MD

The TCT 2024 Career Achievement Award will be presented to Robert A. Harrington, MD, during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientif

TCT 2024 Career Achievement Award to be Presented to Robert A. Harrington, MD - Vimarsana News

TCT 2024 Career Achievement Award to be Presented to Robert A. Harrington, MD

The TCT 2024 Career Achievement Award will be presented to Robert A. Harrington, MD, during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientif

Cardiovascular Research Foundation Announces TCT 2023 Award Winners - Vimarsana News

Cardiovascular Research Foundation Announces TCT 2023 Award Winners

The recipients of two prestigious awards — the Career Achievement Award and the TCT Geoffrey O. Hartzler Master Operator Award — have been announced by the Cardiovascular Research Foundation (CRF) ahead of its annual scientific symposium, the Transcatheter Cardiovascular Therapeutics (TCT) conference. TCT 2023, will take place from Monday, October 23 thru Thursday, October 26, 2023 at the Moscone Center in in San Francisco, California.

Empagliflozin may reduce serum uric acid in HF patients, lower mortality risk: EMPEROR-reduced trial - Vimarsana News

Empagliflozin may reduce serum uric acid in HF patients, lower mortality risk: EMPEROR-reduced trial

Germany: In patients with heart failure, hyperuricemia is a common comorbidity and is an independent predictor of advanced disease severity and increased mortality, the researchers' state in a study...

Amphilimus-eluting stents superior to zotarolimus stents in diabetics undergoing PCI: SUGAR trial - Vimarsana News

Amphilimus-eluting stents superior to zotarolimus stents in diabetics undergoing PCI: SUGAR trial

Spain: Cre8 EVO stents (polymer-free amphilimus-eluting stent) are superior to Resolute Onyx stents (polymer-based zotarolimus-eluting stent) in patients with diabetes undergoing PCI with regard to...